Functionally Designed Nanovaccines against SARS-CoV-2 and Its Variants

被引：1
作者：
Xi, Yue [1 ,2 ]
Ma, Rongrong [1 ,2 ,3 ]
Li, Shuo [1 ,2 ,3 ]
Liu, Gang [2 ,3 ,4 ]
Liu, Chao [1 ,2 ,5 ]
机构：
[1] Xiamen Univ, State Key Lab Stress Biol, Xiamen 361102, Peoples R China
[2] Xiamen Univ, Sch Pharmaceut Sci, Fujian Prov Key Lab Innovat Drug Target Res, Xiamen 361102, Peoples R China
[3] Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China
[4] Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China
[5] Xiamen Univ, China Shenzhen Res Inst, Shenzhen 518000, Peoples R China
来源：
VACCINES | 2024年 / 12卷 / 07期
基金：
中国国家自然科学基金;
关键词：
nanovaccines; SARS-CoV-2; functionalization; VACCINE; NANOPARTICLES; COVID-19; DELIVERY; SAFETY; EFFICACY; PHASE-3;
D O I：
10.3390/vaccines12070764
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
COVID-19, generated by SARS-CoV-2, has significantly affected healthcare systems worldwide. The epidemic has highlighted the urgent need for vaccine development. Besides the conventional vaccination models, which include live-attenuated, recombinant protein, and inactivated vaccines, nanovaccines present a distinct opportunity to progress vaccine research and offer convenient alternatives. This review highlights the many widely used nanoparticle vaccine vectors, outlines their benefits and drawbacks, and examines recent developments in nanoparticle vaccines to prevent SARS-CoV-2. It also offers a thorough overview of the many advantages of nanoparticle vaccines, including an enhanced host immune response, multivalent antigen delivery, and efficient drug delivery. The main objective is to provide a reference for the development of innovative antiviral vaccines.
引用
收藏
页数：18
相关论文
共 121 条
[61]   Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [J].
Lu, Ying ;
Liu, Ze-Hui ;
Li, Ying-Xiang ;
Xu, Hui-Ling ;
Fang, Wei-Huan ;
He, Fang .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2022, 17 :1593-1608
[62]   Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy [J].
Mao, Liuzhou ;
Ma, Panqin ;
Luo, Xi ;
Cheng, Hongwei ;
Wang, Zhanxiang ;
Ye, Enyi ;
Loh, Xian Jun ;
Wu, Yun-Long ;
Li, Zibiao .
ACS NANO, 2023, 17 (11) :9826-9849
[63]   Assembly, Engineering and Applications of Virus-Based Protein Nanoparticles [J].
Mateu, Mauricio G. .
PROTEIN-BASED ENGINEERED NANOSTRUCTURES, 2016, 940 :83-120
[64]   SARS-CoV-2 Variants, Vaccines, and Host Immunity [J].
Mistry, Priyal ;
Barmania, Fatima ;
Mellet, Juanita ;
Peta, Kimberly ;
Strydom, Adele ;
Viljoen, Ignatius M. ;
James, William ;
Gordon, Siamon ;
Pepper, Michael S. .
FRONTIERS IN IMMUNOLOGY, 2022, 12
[65]   Engineering precision nanoparticles for drug delivery [J].
Mitchell, Michael J. ;
Billingsley, Margaret M. ;
Haley, Rebecca M. ;
Wechsler, Marissa E. ;
Peppas, Nicholas A. ;
Langer, Robert .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (02) :101-124
[66]   Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development [J].
Miyamoto, Sho ;
Suzuki, Tadaki .
VACCINE, 2024, 42 (06) :1401-1406
[67]   Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2 [J].
Mohamed, Nura A. ;
Abou-Saleh, Haissam ;
Mohamed, Hana A. ;
Al-Ghouti, Mohammad A. ;
Crovella, Sergio ;
Zupin, Luisa .
VIRUSES-BASEL, 2022, 14 (07)
[68]   Boosting dendritic cell nanovaccines [J].
Mohammadzadeh, Yahya ;
De Palma, Michele .
NATURE NANOTECHNOLOGY, 2022, 17 (05) :442-444
[69]   Nanotechnology Toolkit for Combating COVID-19 and Beyond [J].
Muthiah, Giredhar ;
Sarkar, Ankita ;
Roy, Shounak ;
Singh, Prem ;
Kumar, Praveen ;
Bhardwaj, Keshav ;
Jaiswal, Amit .
CHEMNANOMAT, 2022, 8 (04)
[70]   Cell membrane coated nanoparticles: next-generation therapeutics [J].
Narain, Ashwin ;
Asawa, Simran ;
Chhabria, Vikesh ;
Patil-Sen, Yogita .
NANOMEDICINE, 2017, 12 (21) :2677-2692
234567891011